Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Completed · Phase 3 · Has a placebo group

Conditions studied: Plaque Psoriasis

In brief

Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis

Key facts

Study ID

NCT00691964

Run by

AbbVie (prior sponsor, Abbott)

People needed

347

Starts

2008-05-01

Expected to finish

2009-03-01

Last updated by the study team

2013-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Psoriasis for 6 mo.
• BSA 10%, PASI 12 or above, PGA 3 or above

You may not qualify if…

• Previous exposure to either etanercept or ABT-874

Where it is running

• Site Reference ID/Investigator# 8478 — Tucson, Arizona, United States
• Site Reference ID/Investigator# 8462 — Fresno, California, United States
• Site Reference ID/Investigator# 8454 — Los Angeles, California, United States
• Site Reference ID/Investigator# 8476 — Denver, Colorado, United States
• Site Reference ID/Investigator# 9641 — Miami, Florida, United States
• Site Reference ID/Investigator# 8463 — Alpharetta, Georgia, United States
• Site Reference ID/Investigator# 8479 — Arlington Heights, Illinois, United States
• Site Reference ID/Investigator# 8527 — Schaumburg, Illinois, United States
• Site Reference ID/Investigator# 9001 — Skokie, Illinois, United States
• Site Reference ID/Investigator# 8466 — West Dundee, Illinois, United States
• Site Reference ID/Investigator# 8467 — Indianapolis, Indiana, United States
• Site Reference ID/Investigator# 8464 — Boston, Massachusetts, United States
• Site Reference ID/Investigator# 8459 — St Louis, Missouri, United States
• Site Reference ID/Investigator# 8473 — East Windsor, New Jersey, United States
• Site Reference ID/Investigator# 8457 — New Brunswick, New Jersey, United States
• Site Reference ID/Investigator# 8447 — Albuquerque, New Mexico, United States
• Site Reference ID/Investigator# 8475 — New York, New York, United States
• Site Reference ID/Investigator# 8468 — Cincinnati, Ohio, United States
• Site Reference ID/Investigator# 8460 — Cleveland, Ohio, United States
• Site Reference ID/Investigator# 9762 — Oklahoma City, Oklahoma, United States
• Site Reference ID/Investigator# 8480 — Lake Oswego, Oregon, United States
• Site Reference ID/Investigator# 8469 — Portland, Oregon, United States
• Site Reference ID/Investigator# 9566 — Portland, Oregon, United States
• Site Reference ID/Investigator# 9761 — Hershey, Pennsylvania, United States
• Site Reference ID/Investigator# 8471 — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.